Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal (UVV) Other financing activities (2016 - 2025)

Universal's Other financing activities history spans 12 years, with the latest figure at -$5.1 million for Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to -$5.1 million; the TTM value through Dec 2025 reached -$12.9 million, down 195.91%, while the annual FY2025 figure was -$3.7 million, 2.99% down from the prior year.
  • Other financing activities for Q4 2025 was -$5.1 million at Universal, down from -$3.7 million in the prior quarter.
  • Across five years, Other financing activities topped out at $97000.0 in Q1 2022 and bottomed at -$5.1 million in Q4 2025.
  • The 5-year median for Other financing activities is -$599000.0 (2021), against an average of -$1.7 million.
  • The largest annual shift saw Other financing activities plummeted 2868.42% in 2021 before it soared 104.08% in 2022.
  • A 5-year view of Other financing activities shows it stood at -$268000.0 in 2021, then crashed by 1567.16% to -$4.5 million in 2022, then skyrocketed by 99.78% to -$10000.0 in 2023, then tumbled by 3090.0% to -$319000.0 in 2024, then plummeted by 1513.17% to -$5.1 million in 2025.
  • Per Business Quant, the three most recent readings for UVV's Other financing activities are -$5.1 million (Q4 2025), -$3.7 million (Q3 2025), and -$4.0 million (Q2 2025).